Serum adropin levels in patients with migraine

Basit Öğe Kaydı
dc.authoridAlgul, Fatma Ebru/0000-0003-0318-7571
dc.contributor.authorAlgul, Fatma Ebru
dc.contributor.authorTosun, Hatice
dc.date.accessioned2024-08-04T21:01:08Z
dc.date.available2024-08-04T21:01:08Z
dc.date.issued2024
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAim: In this study, we aimed to investigate the relationship between migraine and serum adropin levels. Material and Methods: This is a randomized control study. The study was conducted for 6 months starting from January 2021. Fifty-four migraine patients were selected for the study as a case group and matched with 35 healthy participants for the control group. We compared serum adropin, high -density lipoprotein (HDL-C), low -density lipoprotein (LDL-C), total cholesterol (TC) and triglyceride (TG) concentration and body -mass index (BMI) between the case and control groups. In addition, the relationship between migraine disease duration, monthly pain frequency and pain duration, and serum adropin level in the patient group was analyzed. Results: There was no significant difference between the two groups regarding age, gender, triglyceride, LDL-C, HDL-C, BMI levels and serum adropin levels (p<0.05). Also, there was no significant difference in migraine disease duration, frequency of headache (within a month) and headache duration depending on serum adropin levels. A negative correlation was determined between adropin levels and age and BMI (p<0.05). Discussion: Serum adropin concentrations are not associated with migraine in our population. Besides, serum adropin levels decrease with increasing BMI and with age. With this knowledge, however, it is difficult to make a definitive conclusion. Further studies with larger populations are needed.en_US
dc.identifier.doi10.4328/ACAM.21706
dc.identifier.endpage88en_US
dc.identifier.issn2667-663X
dc.identifier.issue2en_US
dc.identifier.startpage85en_US
dc.identifier.urihttps://doi.org/10.4328/ACAM.21706
dc.identifier.urihttps://hdl.handle.net/11616/104105
dc.identifier.volume15en_US
dc.identifier.wosWOS:001157822900014en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherBayrakol Medical Publisheren_US
dc.relation.ispartofAnnals of Clinical and Analytical Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMigraineen_US
dc.subjectAdropinen_US
dc.subjectBody Mass Indexen_US
dc.subjectNitric Oxideen_US
dc.titleSerum adropin levels in patients with migraineen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu